SCHEMBL6931910

SCHEMBL6931910

CCCCN(CC(O)COc1ccccc1)CC(O)COc1ccccc1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 2/20 0.69
KDM4E B2RXH2 1/20 0.69
TDP1 Q9NUW8 1/20 0.69
POLB P06746 2/20 0.63
MEN1 O00255 1/20 0.60
KMT2A Q03164 1/20 0.60
NPSR1 Q6W5P4 2/20 0.54
ALDH1A1 P00352 4/20 0.50
MAPT P10636 2/20 0.50
LMNA P02545 2/20 0.50
GAA P10253 1/20 0.50
CYP2D6 P10635 2/20 0.49
CYP1A2 P05177 1/20 0.49
CYP2C9 P11712 1/20 0.49
CYP2C19 P33261 1/20 0.49
TSHR P16473 2/20 0.49
ADRB2 P07550 1/20 0.49
ADRB1 P08588 1/20 0.49
ADRB3 P13945 1/20 0.49
HIF1A Q16665 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11882594 0.91 MAPK1 (0.63) MAPK1KDM4ETDP1POLBMEN1
SCHEMBL13299368 0.87 ABCB1 (0.67) MAPK1KDM4ETDP1POLBMEN1
SCHEMBL11882590 0.86 MAPK1 (0.53) MAPK1KDM4ETDP1POLBMEN1
SCHEMBL10760842 0.85 POLB (0.78) MAPK1KDM4ETDP1POLBALDH1A1
SCHEMBL13952042 0.85 POLB (0.78) MAPK1KDM4ETDP1POLBALDH1A1
SCHEMBL9787234 0.84 MAPK1 (0.52) MAPK1KDM4ETDP1POLBMEN1
SCHEMBL9787231 0.84 MAPK1 (0.52) MAPK1KDM4ETDP1POLBMEN1
SCHEMBL759782 0.84 ALDH1A1 (0.67) MAPK1KDM4ETDP1POLBNPSR1
SCHEMBL15296872 0.82 POLB (0.53) MAPK1KDM4ETDP1POLBMEN1
SCHEMBL13299376 0.82 ABCB1 (0.61) MAPK1KDM4ETDP1POLBMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200261442-A1 TARGETED DRUG RESCUE WITH NOVEL COMPOSITIONS, COMBINATIONS, AND METHODS THEREOF VEPACHEDU SREENIVASARAO (US) 2020-08-20 US disclosed
US-20200069674-A1 TARGETED DRUG RESCUE WITH NOVEL COMPOSITIONS, COMBINATIONS, AND METHODS THEREOF Exciva GmbH (DE) 2020-03-05 US disclosed
EP-0658583-B1 Epoxy resin-hardener system having elastic properties SOLUTIA GERMANY GMBH & CO KG (DE) 2003-04-16 EP disclosed
EP-0658584-B1 Epoxy resin-hardener system having elastic properties SOLUTIA GERMANY GMBH & CO KG (DE) 2002-05-22 EP disclosed
EP-0617069-B1 Curable, powdery mixtures HOECHST AG (DE) 2000-11-02 EP disclosed
EP-0387692-B1 Curable powdry mixtures HOECHST AG (DE) 1997-07-16 EP disclosed
US-5585446-A EPOXY RESIN ADHESIVE COMPOSITION HOECHST AKTIENGESELLSCHAFT (DE) 1996-12-17 US disclosed
US-5567782-A ELASTIC ADHESIVE HOECHST AKTIENGESELLSCHAFT (DE) 1996-10-22 US disclosed
EP-0703258-A2 Curable, powdery mixtures HOECHST AKTIENGESELLSCHAFT (DE) 1996-03-27 EP disclosed
US-5459208-A Elasticity at low temperatures; automobile structural adhesive HOECHST AKTIENGESELLSCHAFT (DE) 1995-10-17 US disclosed
EP-0675185-A2 Elastic amine-modified epoxy resin composition HOECHST AKTIENGESELLSCHAFT (DE) 1995-10-04 EP disclosed
EP-0658583-A2 Epoxy resin-hardener system having elastic properties HOECHST AKTIENGESELLSCHAFT (DE) 1995-06-21 EP disclosed
EP-0658584-A2 Epoxy resin-hardener system having elastic properties HOECHST AKTIENGESELLSCHAFT (DE) 1995-06-21 EP disclosed
EP-0617069-A2 Curable, powdery mixtures HOECHST AKTIENGESELLSCHAFT (DE) 1994-09-28 EP disclosed
US-4997907-A Polyester, epoxy compound HOECHST AKTIENGESELLSCHAFT (DE) 1991-03-05 US disclosed
EP-0387692-A2 Curable powdry mixtures HOECHST AKTIENGESELLSCHAFT (DE) 1990-09-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200069674-A1 TARGETED DRUG RESCUE WITH NOVEL COMPOSITIONS, COMBINATIONS, AND METHODS THEREOF HTR2A, HTR2C, CYP3A43 MAPK1 3886/4885KDM4E 3464/4885TDP1 760/4885
US-20200261442-A1 TARGETED DRUG RESCUE WITH NOVEL COMPOSITIONS, COMBINATIONS, AND METHODS THEREOF HTR2C, HTR2A, HTR3A MAPK1 3827/4885KDM4E 2088/4885TDP1 1033/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.